Lizbeth Hoos

4.9k total citations · 2 hit papers
30 papers, 4.0k citations indexed

About

Lizbeth Hoos is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Lizbeth Hoos has authored 30 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 10 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Lizbeth Hoos's work include Cholesterol and Lipid Metabolism (17 papers), Drug Transport and Resistance Mechanisms (10 papers) and Diabetes Treatment and Management (7 papers). Lizbeth Hoos is often cited by papers focused on Cholesterol and Lipid Metabolism (17 papers), Drug Transport and Resistance Mechanisms (10 papers) and Diabetes Treatment and Management (7 papers). Lizbeth Hoos collaborates with scholars based in United States, United Kingdom and France. Lizbeth Hoos's co-authors include Harry R. Davis, Glen Tetzloff, S. Altmann, Michael P. Graziano, Li-Ji Zhu, Xiaorui Yao, Maureen Maguire, Sai Prasad N. Iyer, Douglas S. Compton and Andrei Golovko and has published in prestigious journals such as Science, Journal of Biological Chemistry and Diabetes.

In The Last Decade

Lizbeth Hoos

30 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption

2004 1.4k citations S. Altmann, Harry R. Davis et al. Science profile →
Niemann-Pick C1 Like 1 (NPC1L1) Is the Intestinal Phytosterol and Cholesterol Transporter and a Key Modulator of Whole-body Cholesterol Homeostasis

2004 566 citations Harry R. Davis, Li-Ji Zhu et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lizbeth Hoos United States	22	2.8k	1.3k	1.3k	787	661	30	4.0k
Glen Tetzloff United States	20	2.3k 0.8×	1.2k 0.9×	1.2k 1.0×	660 0.8×	493 0.7×	31	3.4k
Philippe Costet France	32	3.2k 1.1×	1.1k 0.8×	2.1k 1.6×	631 0.8×	644 1.0×	45	4.5k
Carl P. Sparrow United States	29	2.1k 0.8×	730 0.6×	2.0k 1.5×	478 0.6×	498 0.8×	48	4.4k
Sophie Lestavel France	29	1.7k 0.6×	763 0.6×	2.0k 1.5×	750 1.0×	542 0.8×	62	3.8k
Omar L. Francone United States	34	3.6k 1.3×	1.6k 1.2×	2.5k 2.0×	1.3k 1.6×	946 1.4×	71	5.2k
Alfredo Cantàfora Italy	33	1.6k 0.6×	765 0.6×	847 0.7×	492 0.6×	347 0.5×	120	3.4k
S D Turley United States	18	2.7k 1.0×	1.3k 1.0×	1.5k 1.2×	602 0.8×	475 0.7×	22	4.0k
Ashok K. Batta United States	33	2.6k 0.9×	1.5k 1.2×	1.8k 1.4×	422 0.5×	337 0.5×	81	4.2k
Pieter H.E. Groot Netherlands	38	1.6k 0.6×	1.0k 0.8×	1.8k 1.4×	1.2k 1.5×	756 1.1×	91	5.1k
Keith E. Suckling United Kingdom	29	2.1k 0.7×	457 0.4×	1.6k 1.2×	731 0.9×	779 1.2×	123	4.1k

Countries citing papers authored by Lizbeth Hoos

Since Specialization

Citations

This map shows the geographic impact of Lizbeth Hoos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lizbeth Hoos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lizbeth Hoos more than expected).

Fields of papers citing papers by Lizbeth Hoos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lizbeth Hoos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lizbeth Hoos. The network helps show where Lizbeth Hoos may publish in the future.

Co-authorship network of co-authors of Lizbeth Hoos

This figure shows the co-authorship network connecting the top 25 collaborators of Lizbeth Hoos. A scholar is included among the top collaborators of Lizbeth Hoos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lizbeth Hoos. Lizbeth Hoos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Tian‐Quan, Weizhen Wu, Myung K. Shin, et al.. (2015). Factor XII full and partial null in rat confers robust antithrombotic efficacy with no bleeding. Blood Coagulation & Fibrinolysis. 26(8). 893–902. 20 indexed citations

Xu, Yiming, Tian‐Quan Cai, Gino Castriota, et al.. (2013). Factor XIIa inhibition by Infestin-4: in vitro mode of action and in vivo antithrombotic benefit. Thrombosis and Haemostasis. 111(4). 694–704. 50 indexed citations

Vassileva, Galya, Weiwen Hu, Lizbeth Hoos, et al.. (2010). Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice. Journal of Endocrinology. 205(3). 225–232. 68 indexed citations

Tremblay, André, Benoı̂t Lamarche, Valéry Lemelin, et al.. (2010). Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men. Journal of Lipid Research. 52(3). 558–565. 81 indexed citations

Zheng, Shuqin, Lizbeth Hoos, John A. Cook, et al.. (2008). Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice. European Journal of Pharmacology. 584(1). 118–124. 145 indexed citations

Vassileva, Galya, Andrei Golovko, Susan J. Abbondanzo, et al.. (2006). Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. Biochemical Journal. 398(3). 423–430. 229 indexed citations

Kowalski, Timothy J., Brian D. Spar, Mandy J. Maguire, et al.. (2005). Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice. Journal of Endocrinology. 185(1). 151–164. 59 indexed citations

Davis, Harry R., Li-Ji Zhu, Lizbeth Hoos, et al.. (2004). Niemann-Pick C1 Like 1 (NPC1L1) Is the Intestinal Phytosterol and Cholesterol Transporter and a Key Modulator of Whole-body Cholesterol Homeostasis. Journal of Biological Chemistry. 279(32). 33586–33592. 566 indexed citations breakdown →

Altmann, S., Harry R. Davis, Li-Ji Zhu, et al.. (2004). Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption. Science. 303(5661). 1201–1204. 1393 indexed citations breakdown →

10.

Heek, Margaret van, Constance Farley, Douglas S. Compton, et al.. (2003). Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats. British Journal of Pharmacology. 138(8). 1459–1464. 51 indexed citations

11.

Altmann, S., Harry R. Davis, Xiaorui Yao, et al.. (2002). The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1580(1). 77–93. 124 indexed citations

12.

Heek, Margaret van, Constance Farley, Douglas S. Compton, Lizbeth Hoos, & Harry R. Davis. (2001). Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. British Journal of Pharmacology. 134(2). 409–417. 173 indexed citations

13.

Davis, Harry R., Douglas S. Compton, Lizbeth Hoos, & Glen Tetzloff. (2001). Ezetimibe, a Potent Cholesterol Absorption Inhibitor, Inhibits the Development of Atherosclerosis in ApoE Knockout Mice. Arteriosclerosis Thrombosis and Vascular Biology. 21(12). 2032–2038. 180 indexed citations

14.

Heek, Margaret van, Constance Farley, Douglas S. Compton, et al.. (2000). Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. British Journal of Pharmacology. 129(8). 1748–1754. 265 indexed citations

15.

Heek, Margaret van, Constance Farley, Douglas S. Compton, et al.. (2000). The potent cholesterol absorption inhibitor, ezetimibe, is glucuronidated in the intestine, localizes to the intestine, and circulates enterohepatically. Atherosclerosis. 151(1). 155–155. 9 indexed citations

16.

Davis, Harry R., Deborra Mullins, Jesse M. Pines, et al.. (1998). Effect of Chronic Central Administration of Glucagon‐Like Peptide‐1 (7–36) Amide on Food Consumption and Body Weight in Normal and Obese Rats. Obesity Research. 6(2). 147–156. 49 indexed citations

17.

Heek, Margaret van, Donald E. Mullins, Michael D. Wirth, et al.. (1996). The Relationship of Tissue Localization, Distribution and Turnover to Feeding After Intraperitoneal¹²⁵I-Leptin Administration toob/obanddb/dbMice. Hormone and Metabolic Research. 28(12). 653–658. 45 indexed citations

18.

Salisbury, Brian, Harry R. Davis, Robert E. Burrier, et al.. (1995). Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461. Atherosclerosis. 115(1). 45–63. 94 indexed citations

19.

Burrier, Robert E., et al.. (1994). Demonstration of a direct effect on hepatic acyl CoA:cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster. Biochemical Pharmacology. 47(9). 1545–1551. 23 indexed citations

20.

Pula, Kathryn, et al.. (1993). NG-Nitro-L-arginine Methyl Ester Does Not Affect Balloon Catheter-Induced Intimal Hyperplasia in Rats. Biochemical and Biophysical Research Communications. 197(1). 304–309. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact